StockData
Lipocine Inc. logo

Lipocine Inc. (LPCN) stock

LPCNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3042% below fair value
$1.48−0.02 (-1.33%)

Close on Nov 20, 2026Market cap $12.20MP/E –Yield –

Lipocine gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Lipocine

Lipocine has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Lipocine figures

See a number that looks wrong?